CORRESP Filing
BioCardia, Inc.
Date: July 15, 2025 · CIK: 0000925741 · Accession: 0001437749-25-022729
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288592
Letter
bcda20250714_corresp.htm
BioCardia, Inc.
320 Soquel Way
Sunnyvale, California 94085
July 15, 2025
Via EDGAR
U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE
Washington, D.C. 20549-3561
Attn: Joshua Gorsky
Re:
BioCardia, Inc.
Registration Statement on Form S-3
Filed July 9, 2025
File No. 333-288592
Acceleration Request
Requested Date: July 17, 2025
Requested Time: 4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-288592) (the “Registration Statement”), be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission.
The Company hereby authorizes Austin March of Wilson Sonsini Goodrich & Rosati, P.C., counsel for the Company, to make such request on the Company’s behalf.
The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Austin March at (512) 338-5410 or amarch@wsgr.com.
Sincerely,
BIOCARDIA, INC.
Show Raw Text
CORRESP 1 filename1.htm bcda20250714_corresp.htm BioCardia, Inc. 320 Soquel Way Sunnyvale, California 94085 July 15, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549-3561 Attn: Joshua Gorsky Re: BioCardia, Inc. Registration Statement on Form S-3 Filed July 9, 2025 File No. 333-288592 Acceleration Request Requested Date: July 17, 2025 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-288592) (the “Registration Statement”), be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission. The Company hereby authorizes Austin March of Wilson Sonsini Goodrich & Rosati, P.C., counsel for the Company, to make such request on the Company’s behalf. The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Austin March at (512) 338-5410 or amarch@wsgr.com. Sincerely, BIOCARDIA, INC. By: /s/ David McClung David McClung Chief Financial Officer cc: Peter Altman, BioCardia, Inc. Austin March, Esq., Wilson Sonsini Goodrich & Rosati, P.C.